---

Related Articles:

Drug delivery systems for the topical treatment of cutaneous leishmaniasis.

2012-09-01

[Expert Opin. Drug Deliv. 9(9) , 1083-97, (2012)]

In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys.

2003-11-01

[J. Vet. Med. Sci. 65(11) , 1171-7, (2003)]

Design, synthesis and in vitro evaluation of novel water-soluble prodrugs of buparvaquone.

2004-10-01

[Eur. J. Pharm. Sci. 23(2) , 151-8, (2004)]

The protozoan parasite Theileria annulata alters the differentiation state of the infected macrophage and suppresses musculoaponeurotic fibrosarcoma oncogene (MAF) transcription factors.

2009-08-01

[Int. J. Parasitol. 39(10) , 1099-108, (2009)]

Clinical efficacy and plasma concentrations of two formulations of buparvaquone in cattle infected with East Coast fever (Theileria parva infection).

2006-08-01

[Res. Vet. Sci. 81(1) , 119-26, (2006)]